Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.2B | 14.5B | 14.1B | 13.5B |
Cost of revenue | 7.3B | 7.2B | 7.9B | 7.0B |
Gross profit | 7.9B | 7.3B | 6.2B | 6.5B |
Operating expense | ||||
Research & development | 1.1B | 1.1B | 1.1B | 1.0B |
Selling general and admin | 1.6B | 1.5B | 2.0B | 1.5B |
Other operating expenses | — | — | — | — |
Operating income | 5.2B | 4.6B | 3.1B | 4.0B |
Non operating interest income | ||||
Income | 54.5M | 70.0M | 74.4M | — |
Expense | 251.2M | 253.3M | 264.9M | 284.1M |
Other income expense | — | — | — | — |
Pretax income | 5.0B | 4.4B | 2.9B | 3.7B |
Tax provision | 696.4M | 444.8M | 365.4M | 466.9M |
Net income | 4.3B | 4.0B | 2.6B | 3.3B |
Basic EPS | 0.2 | 0.2 | 0.1 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.1 | 0.2 |
Basic average shares | 20.4B | 20.5B | 20.5B | 20.6B |
Diluted average shares | 20.9B | 21.0B | 21.0B | 21.0B |
EBITDA | 10.6B | 10.0B | 9.0B | 9.2B |
Net income from continuing op. | 4.3B | 4.0B | 2.6B | 3.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |